FIELD: medicine, pharmaceutics.
SUBSTANCE: present group of inventions refers to medicine, namely to neurology, and concerns treating infectious diseases accompanied by neurotoxic disorders. That is ensured by administering a pharmaceutical composition containing an activated-potentiated form of human gamma-interferon (IFN-γ) antibodies and an activated-potentiated form of brain-specific protein S-100 antibodies.
EFFECT: drug preparation provides effective treatment of the above pathology ensured by the synergetic action of the ingredients of the composition.
9 cl, 4 dwg, 1 tbl, 2 ex
